| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e60572932b2dff2e813c0c1c71fdd73b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6d7693e73603a673791656f84cb0610c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9adfd8615849e9c22cdc691df7f8b6ed
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_36a40779d086bbdc932ceb8eb481f164
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e388911162aa60ca4fbf1d0dc2a6bca1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3bb2478d0f04555a7bd1c187cc33a759 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B30-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C40B40-06 |
| filingDate |
2010-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_181659327f20a42fdc1c1f946bcdc35f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4dfca601bc321712d15d4d9074c08860
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3604fa9986fad997293c663af818388e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_91b7949b3e36e6040f58abe62360cf04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01f830a8eecd379062e70ffb65075ff2 |
| publicationDate |
2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2013023432-A1 |
| titleOfInvention |
Method for predicting therapeutic effect of immunotherapy on cancer patient and/or prognosis after immunotherapy, and gene set and kit to be used therin |
| abstract |
The present invention provides a method for predicting effect of immunotherapy on a cancer patient and/or prognosis of the cancer patient after the immunotherapy, and a gene set and a kit for use in the method. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3944863-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022023192-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020165361-A1 |
| priorityDate |
2009-10-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |